pcos and semaglutide & Tirzepatide with PCOS: Envizion Medical: Wellness Center Semaglutide & Tirzepatide with PCOS:

Helps promote feelings of fullness and appetite awareness*

Could GLP-1 drugs be used to fight Alzheimer's disease

Kalah will join fellow panelists Wade Ackerman, Sean Griffin and Scott Brunner, CAE for the session, Taking Shape: The Legislative and Regulatory Landscape for GLP-1s. Together, the panel will explore: Pending legislation impacting GLP-1 marketing, manufacturing, compounding, and access FDA enforcement activity and evolving regulatory posture Drug pricing and Medicare negotiation implications State AG activity and broader policy pressures influencing regulators How companies can prepare for pending and potential legislation before it takes effect If youll be attending the summit, be sure to add this discussion to your agenda

One key finding: GLP-1 initiation among this group increased from 1.1% in 2020 to 7.3% in 2024

Book your free consult.